Insiders Hikma Pharmaceuticals PLC

Equities

Real-time Estimate Cboe Europe Other stock markets 04:17:25 2024-05-01 am EDT			5-day change	1st Jan Change
1,929 ^GBX	+0.26%		+5.88%	+7.66%

Apr. 26	HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets
Apr. 25	Hikma Pharmaceuticals plc Approves Final Dividend, Payable on 3 May 2024	CI

Hikma Pharmaceuticals PLC Announces Executive Changes	Apr. 15	CI
Hikma Pharmaceuticals PLC Announces Board Changes	Feb. 22	CI
Hikma Pharmaceuticals PLC Announces Company Secretary Change	Dec. 29	CI
Hikma Pharmaceuticals PLC Appoints Bill Larkins as President of Its Injectables Business, Effective 1 September 2023	23-08-09	CI
Hikma Pharmaceuticals PLC Approves Board Changes	23-04-28	CI
Hikma Pharmaceutical appoints Injectables lead Mishlawi as new CEO	23-04-12	AN
Hikma Pharma names Mishlawi as next CEO	23-04-12	RE
Hikma Pharmaceuticals Names Injectables Head as New CEO	23-04-12	MT
Hikma Pharmaceuticals PLC Announces CEO Changes	23-04-12	CI
Hikma Pharmaceuticals PLC Appoints Deneen Vojta as Director	22-10-13	CI
Hikma Pharmaceuticals PLC Announces Board Appointments	22-09-30	CI
Hikma Pharmaceuticals plc Announces Company Secretary Change	22-06-15	CI
Hikma Pharmaceuticals CEO Steps Down; Chairman Assumes Duties	22-05-24	MT
Hikma Pharmaceuticals PLC Announces Chief Executive Officer Changes	22-05-24	CI
Hikma Pharmaceuticals Announces Directorate Change	22-02-24	CI
Hikma Appoints Patrick Genestin to Lead Generics Business Development	21-06-09	CI
Hikma Pharmaceuticals plc Announces Board and Committee Changes	20-11-05	CI
Hikma Pharmaceuticals PLC Announces the Resignation of Dr. Jochen Gann as Director	20-06-25	CI
Hikma Pharmaceuticals PLC Announces the Appointment of Douglas Hurt as an Independent Non-Executive Director, Effective 1 May 2020	20-04-30	CI
Hikma Pharmaceuticals plc Announces Board Changes	20-02-27	CI

No results for this search

HIKMA PHARMACEUTICALS : Hikma’s Q1 progress appreciated by the markets

April 26, 2024 at 06:50 am EDT